Karyopharm Therapeutics Inc (KPTI) — Financial Flexibility Index
Karyopharm Therapeutics Inc (KPTI) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of $-11.83 Million (operating CF $-11.83 Million minus capex $0.00) represents 0% of total liabilities ($401.34 Million). Check Karyopharm Therapeutics Inc (KPTI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Karyopharm Therapeutics Inc Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Karyopharm Therapeutics Inc across 15 annual periods. See how liquid is Karyopharm Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Karyopharm Therapeutics Inc (2011–2025)
Year-by-year free cash flow to debt coverage for Karyopharm Therapeutics Inc. For the full company profile including market capitalisation, see KPTI market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | $-75.37 Million | $-75.37 Million | $401.34 Million | ▲ +48.3% |
| 2024 | -0.36x | $-127.34 Million | $-127.49 Million | $350.44 Million | ▼ -47.6% |
| 2023 | -0.25x | $-92.72 Million | $-92.72 Million | $376.64 Million | ▲ +38.3% |
| 2022 | -0.40x | $-149.44 Million | $-149.55 Million | $374.83 Million | ▼ -51.4% |
| 2021 | -0.26x | $-101.40 Million | $-107.12 Million | $384.98 Million | ▲ +56.8% |
| 2020 | -0.61x | $-160.09 Million | $-160.23 Million | $262.50 Million | ▲ +21.6% |
| 2019 | -0.78x | $-190.62 Million | $-190.82 Million | $245.19 Million | ▲ +21.6% |
| 2018 | -0.99x | $-156.75 Million | $-159.12 Million | $158.02 Million | ▲ +31.5% |
| 2017 | -1.45x | $-73.66 Million | $-73.72 Million | $50.83 Million | ▲ +68.8% |
| 2016 | -4.65x | $-84.32 Million | $-84.39 Million | $18.14 Million | ▲ +14.3% |
| 2015 | -5.42x | $-92.61 Million | $-94.03 Million | $17.08 Million | ▼ -51.1% |
| 2014 | -3.59x | $-48.61 Million | $-51.45 Million | $13.54 Million | ▲ +60.9% |
| 2013 | -9.18x | $-30.23 Million | $-30.29 Million | $3.29 Million | ▼ -1642.0% |
| 2012 | -0.53x | $-15.39 Million | $-15.51 Million | $29.19 Million | ▼ -28.2% |
| 2011 | -0.41x | $-8.17 Million | $-8.55 Million | $19.88 Million | — |